Teleios Health logo

Teleios Health Review

Best for: physician-prescribed compounded GLP-1 from a $99/mo floor

5.0
★★☆☆2.5/5

Teleios Health is a solid telehealth option with balanced features and pricing.

Teleios Health is a physician-led, cash-pay GLP-1 weight-loss platform marketing compounded semaglutide from $99/mo and compounded tirzepatide from $139/mo, delivered direct to your door through a fully online intake. It emphasizes physician (MD/DO) prescribing rather than an NP-only model. Those starting prices are among the lowest published in the cash-pay segment, though maintenance-dose pricing and other plan details aren't surfaced publicly.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedSemaglutideTirzepatide100% Online IntakeCash-Pay OnlyDirect-To-Door DeliveryPhysician-Prescribed

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Vetted alternatives to Teleios Health

8.2/ 10
Verified partner

Enhance MD

Best for: lab-monitored compounded GLP-1 with mandatory video visit

★★★★4.1/5

Editorial score · methodology

$112/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Enhance MD review →
7.1/ 10
Verified partner

MEDVi

Best for: patients who want the option to switch between compounded and brand-name GLP-1 through one provider

★★★3.6/5

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full MEDVi review →
7.3/ 10
Verified partner

Liv Body

Best for: compounded GLP-1 paired with a muscle-preservation supplement stack

★★★3.7/5

Editorial score · methodology

$179/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Liv Body review →
Teleios Health logo
2.5 / 5
Our editorial rating
Visit Teleios Health

from $99/mo · no insurance needed

Teleios Health at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$99/mo
FDA status
No FDA warning letter on record

How we scored Teleios Health

Each dimension is scored algorithmically from Teleios Health’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.

Value25%

6.4/10

At $99/mo, Teleios Health runs about 41% below the $169 median for GLP-1 providers.

Effectiveness25%

5.6/10

Teleios Health offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.

User Experience15%

4.7/10

Online intake and platform experience; 7 platform features disclosed.

Trust & Safety15%

4.2/10

Some details we couldn't independently confirm; no FDA warning letters on file; dispenses through an accredited compounding pharmacy (last checked 2026-06-06).

Accessibility10%

3.6/10

Teleios Health's exact state footprint isn't published — confirm coverage in your state before signing up.

Support10%

3.4/10

Teleios Health provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
482providers compared
100%verified against live provider sites
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this Teleios Health review

Last checked July 2026
  • Confirmed current pricing across 2 dose/plan tiers
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the public intake/checkout flow on the provider's site

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: low.

What to expect when you sign up with Teleios Health

We walked Teleios Health’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Complete a 2-minute assessment about your health history and weight-loss goals — prices are shown up front (compounded semaglutide and tirzepatide both starting at $99/mo, medication and clinical care included)
  2. 2A licensed physician in your state reviews your assessment and creates a personalized treatment plan
  3. 3Your prescription is dispensed from a licensed U.S. compounding pharmacy and shipped to your door
  4. 4Ongoing clinical support with regular check-ins throughout treatment
Price shown before you start
  • Physician-led, cash-pay GLP-1 weight-loss brand; both semaglutide and tirzepatide advertised starting at $99/mo (as of our July 2026 walk), medication and clinical care included
  • Async 2-minute assessment — no live video visit and no lab work required to start
  • Every prescription reviewed and approved by a licensed provider in the patient's state; medication sourced from licensed U.S. compounding pharmacies
  • 24/7 clinical support included with regular check-ins
  • Compounded medications are not FDA-approved (disclosed site-wide)

GLP-1 medications Teleios Health offers

Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.

Pricing

Prices re-verified

starting tiercompounded injection
$99/mo
semaglutide
starting tiercompounded injection
$139/mo
tirzepatide

Ready to get started?

Plans and promotions change often — check Teleios Health's current pricing and active discounts before you decide.

See Teleios Health pricing →

What we like

  • Compounded semaglutide from $99/mo — among the lowest floor prices in cash-pay telehealth
  • Compounded tirzepatide from a competitive $139/mo floor
  • Markets physician (MD/DO) prescribing rather than an NP-only model
  • Clean meta-tag and SEO implementation

Watch-outs

  • Single-page app: state availability, pharmacy partner, dose pricing, lab requirements, and refund policy aren't visible and couldn't be verified
  • No named medical director, physician, or corporate entity disclosed
  • Year founded unknown — a newer floor-price entrant warranting extra scrutiny
  • No LegitScript, NABP, or SOC 2 trust signal found
  • Heavy paid-acquisition ad-tech stack — pair with diligence on the clinical layer
  • 'From $99/mo' framing hides the maintenance-dose price you'll actually pay

Teleios Health: a rock-bottom floor price that comes with real unknowns

Teleios Health is a cash-pay, online-only weight-loss platform built around one loud promise: compounded semaglutide starting at $99 a month and compounded tirzepatide from a low three-figure floor. That floor is genuinely among the cheapest published numbers in cash-pay telehealth, sitting well under the category median of $169. If the only thing you care about is the smallest possible first number, Teleios earns a look. But the honest verdict is that this is a low-confidence listing: the headline price is the only thing we could firmly verify, and almost everything else a careful buyer would want to know is hidden behind a single-page app that doesn't render its own details. Read this as a 'promising on paper, prove-it-yourself in practice' provider.

How the pricing actually works (and what the floor hides)

The model here is straightforward cash-pay: no insurance, no claims, you pay Teleios directly and the medication ships to your door. Compounded semaglutide is advertised from $99 a month and compounded tirzepatide from a modestly higher floor. There's no teaser or first-month promo rate that we could confirm, so treat $99 as an entry price rather than a limited-time discount.

The catch is baked into the word 'from.' GLP-1 doses escalate over the first few months, and most compounded programs charge more as your dose climbs. Teleios does not publish its per-dose ladder anywhere we could find — the maintenance price you'll actually pay at a therapeutic dose is simply not surfaced. So the $99 figure is best understood as the lowest rung on a ladder whose later rungs are invisible until you're inside the funnel. Before you commit, ask point-blank what the price becomes at the dose you'll likely settle on.

The medications and how they're dispensed

Teleios offers two compounded GLP-1 medications: semaglutide (the molecule in Ozempic and Wegovy) and tirzepatide (the molecule in Mounjaro and Zepbound), both as injections. These are compounded versions, not the brand-name pens — which is how the price gets so low, but also means you're relying on a compounding pharmacy rather than the original manufacturer. Everything runs through a 100% online intake, and the medication is shipped direct to your door.

Here's where the diligence gap bites: Teleios does not name its compounding pharmacy partner anywhere we could verify. With compounded GLP-1s, the pharmacy is the single most important quality signal — its accreditation, sterility practices, and sourcing are what stand between you and a bad batch. A provider that won't tell you who fills your prescription is asking for trust it hasn't yet earned on the page.

What Teleios leans on to stand out: physician prescribing

The one genuine differentiator Teleios markets is its prescriber model. It positions itself as 'physician-led,' emphasizing that an MD or DO writes your prescription rather than the nurse-practitioner-only model many budget competitors run. On paper that's a meaningful distinction — a physician brings deeper training to dosing decisions and managing side effects.

The honest caveat: this claim is a marketing line, not something we could independently confirm. Teleios discloses no named medical director, no individual physician, and no corporate operating entity. 'Physician-led' is only as strong as the credentials behind it, and right now those credentials are asserted rather than shown. It's a reason to be curious, not a reason to be reassured.

Who should choose Teleios, and who should skip it

This provider makes the most sense for a specific kind of shopper: price-driven, comfortable doing their own homework, and willing to ask hard questions over chat or email before paying. If you want the lowest entry price and you'll personally confirm the pharmacy, the dose ladder, and your state's availability, Teleios could work out.

  • Consider it if: you're chasing the floor price, you offer in a state it serves, and you'll vet the clinical details yourself before your first payment.
  • Skip it if: you want transparency up front, a named medical team, a disclosed pharmacy, or a published maintenance-dose price without having to dig for it.
  • Skip it if: you're new to GLP-1s and want maximum hand-holding — a more established, fully transparent provider is worth paying a bit more for.

Trust, safety, and oversight: where our confidence is low

We rate Teleios low-confidence, and it's worth being specific about why. The entire site is a client-side app whose meaningful pages — pricing, how-it-works, FAQ — all return the same empty shell to a crawler, so none of the substantive claims can be independently checked. State availability, BMI eligibility, lab requirements, and refund policy are all unverified. We found no LegitScript, NABP, or SOC 2 trust signal. The year it was founded is unknown, which marks it as a newer floor-price entrant that warrants extra scrutiny. On the positive side, there are no FDA warning letters on file for Teleios in our records — but absence of a red flag is not the same as a green light.

None of this means Teleios is illegitimate. It means the burden of proof sits with you, the buyer, in a way it doesn't with providers who publish their pharmacy, their clinicians, and their full pricing. You can read how we weigh these signals in our scoring methodology.

The bottom line

Teleios Health offers one of the lowest published floor prices in cash-pay GLP-1 telehealth and markets a physician-prescribing model that, if real, is a genuine plus. But it's an opaque, single-page operation that hides almost everything a careful patient needs — the pharmacy, the dose ladder, the states it serves, and the people behind the 'physician-led' label. If you're a confident, price-first shopper who will verify the gaps yourself before paying, the $99 starting price is hard to beat. If you'd rather not gamble on the unknowns, choose a provider that shows its work — even at a higher price than the median.

Shopping around? Embody ($79/month) and bmiMD ($99/month) are the nearest alternatives to Teleios Health in our rankings.

The Bottom Line

Teleios Health is a solid telehealth option with balanced features and pricing.

Score: 5/10Best for: physician-prescribed compounded GLP-1 from a $99/mo floorFrom: $99/mo

Ready to start with Teleios Health?

Starting at $99/month. See current pricing and start your free consultation.

Teleios Health might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
  • If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
  • If you want built-in coaching and behavior-change support, consider MEDVi.

Frequently Asked Questions

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this Teleios Health review:

Sources & methodology — as of July 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy FrameworkU.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board StandardsAccreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)New England Journal of Medicine.PMID: 40334173.

See Teleios Health's current pricing

Plans start at $99/month. Start your free consultation to check eligibility and today's price.